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Introduction
In cells mitochondria fuse and divide continuously with bal-
anced rates, resulting in the formation of highly dynamic 
  reticular networks (Nunnari et al., 1997). Dynamic rearrange-
ments of the mitochondrial network contribute to diverse cel-
lular processes (Youle and Karbowski, 2005; Chan, 2006; 
McBride et al., 2006). For example, the proper regulation of 
mitochondrial fi  ssion and fusion rates appears to be vital for 
Ca
2+ buffering (Szabadkai et al., 2006) and maintenance of 
synaptic plasticity (Li et al., 2004). Mitochondrial fragmenta-
tion and   fusion inhibition are also closely associated with outer 
mitochondrial membrane (OMM) permeabilization and sub-
sequent release of certain proteins from the mitochondria to 
the cytosol, early during apoptosis (Lee et al., 2004; Youle 
and Karbowski, 2005; Estaquier and Arnoult, 2007). The con-
tribution of a balanced mitochondrial network for cellular 
fi  tness was further illuminated by reports showing that muta-
tions of fusion proteins Opa1 and Mfn2 are associated with 
the neurodegenerative diseases dominant optic atrophy and 
Charcot-Marie-Tooth disease, respectively (for review see 
Chan, 2006; McBride et al., 2006).
Mitofusins (Fzo1p in yeast), Opa1 (Mgm1p in yeast), and 
Drp1 (Dnm1p in yeast) are large dynamin-related GTPases 
  essential for mitochondrial fusion and fi  ssion (Otsuga et al., 
1998; Labrousse et al., 1999; Mozdy et al., 2000; Santel and 
Fuller, 2001; Smirnova et al., 2001; Shaw and Nunnari, 2002; 
Chen et al., 2003; Olichon et al., 2007). In addition to Dnm1p, 
mitochondrial fi  ssion in yeast depends on at least three addi-
tional factors. Fis1p is an approximate 18-kD, C-tail–anchored 
integral protein of the OMM (Mozdy et al., 2000) with a tetra-
tricopeptide repeat domain serving as a receptor for Mdv1p 
(Tieu and Nunnari, 2000; Shaw and Nunnari, 2002; Tieu et al., 
2002; Suzuki et al., 2003) or its structural homologue Caf4p 
(Griffi  n et al., 2005). On mitochondria Dnm1p (as well as Drp1) 
localizes to relatively large punctiform structures, particularly 
abundant at prospective scission sites as well as at mitochondrial 
tips (Bleazard et al., 1999; Labrousse et al., 1999; Smirnova et al., 
2001). As detailed recently (Bhar et al., 2006; Naylor et al., 
2006), mitochondrial Dnm1p complexes are dynamic structures 
formed and maintained as a result of transient interactions of 
different components of the fi  ssion machinery. The N-terminal 
extension and the C-terminal WD-40 repeat of Mdv1p or Caf4p 
are thought to act as adaptors linking Fis1p and Dnm1p into the 
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mitochondrial division process (Tieu et al., 2002; Griffi  n et al., 
2005). In contrast to yeast, mitochondrial division in other orga-
nisms, including mammalian cells, is less well understood. As in 
budding yeast, mammalian cells require Drp1 (Smirnova et al., 
2001) and Fis1 (Yoon et al., 2003;   Stojanovski et al., 2004) for 
mitochondrial fi  ssion, suggesting that mitochondrial division 
mechanisms are to some extent   conserved. However, the mecha-
nisms of mitochondrial translocation of Drp1 as well as scission 
foci assembly in mammalian cells remain elusive.
The conjugation of the 76-amino acid protein ubiquitin to 
substrate proteins is involved in the regulation of a variety of 
cellular processes (Hershko and Ciechanover, 1992; Welchman 
et al., 2005) ranging from selective protein degradation to DNA 
repair (Huang and D’Andrea, 2006) and membrane protein traf-
fi  cking (Staub and Rotin, 2006). Recent fi  ndings indicate that 
ubiquitylation plays a direct role in mitochondrial membrane re-
modeling (Neutzner and Youle, 2005; Escobar-Henriques et al., 
2006; Nakamura et al., 2006; Yonashiro et al., 2006). For example, 
it has been shown that treatment with the mating pheromone 
α-factor induces a 26S proteasome-dependent degradation of the 
mitofusin Fzo1p, resulting in the fragmentation of mitochondria 
(Neutzner and Youle, 2005; Escobar-Henriques et al., 2006).
In this study we demonstrate that the mitochondrial E3 
ubiquitin ligase MARCH5 (MarchV) (Bartee et al., 2004; 
Nakamura et al., 2006), also known as MITOL (Yonashiro et al., 
2006), participates in the regulation of mitochondrial division.
Results
Expression of RING domain mutants 
of MARCH5 changes the organization 
of the mitochondrial network
RING fi  nger–containing proteins comprise a large family of 
potential ubiquitin ligases involved in regulation of 26S 
proteasome-dependent degradation of misfolded and superfl  uous 
proteins (Hershko and Ciechanover, 1992) and in signal trans-
duction in various cellular locations (Joazeiro and Weissman, 
2000). Using bioinformatics combined with molecular biol-
ogy techniques, we cloned several uncharacterized RING 
fi  nger proteins associated with mitochondria. One of the mito-
chondrial proteins identifi  ed in our screen was MARCH5 
(RNF153/MarchV), which has been previously described to as-
sociate with the ER (Bartee et al., 2004), and more recently 
shown to localize to mitochondria (Nakamura et al., 2006; 
Yonashiro et al., 2006). MARCH5 consists of four predicted 
transmembrane   domains and an N-terminal RINGv-type RING 
fi  nger domain critical for ubiquitin transfer activity of several 
E3 ubiquitin   ligases (Fig. 1 A). MARCH5 was recently shown 
to mediate ubiquitylation of some mitochondrial proteins, in-
cluding mitochondrial morphogenesis regulators Fis1 and Drp1 
(Nakamura et al., 2006; Yonashiro et al., 2006). However, the role 
of MARCH5 in the regulation of mitochondrial network dy-
namics remains to be clarifi  ed.
When fused with YFP and expressed in HeLa cells, both 
YFP-MARCH5 (unpublished data) and MARCH5-YFP localized 
to mitochondria (Fig.1 B), consistent with two recent studies that 
showed mitochondrial localization of endogenous MARCH5 
(Nakamura et al., 2006; Yonashiro et al., 2006). We failed to detect 
any association of MARCH5 with the ER (unpublished data). 
To analyze the function of MARCH5 we mutated a conserved 
Zn
2+-binding histidine residue inside the RING domain to tryp-
tophan (MARCH5
H43W) (Fig. 1 A). Based on the available RING 
fi  nger protein structure (Katoh et al., 2003; Bottomley et al., 
2005), the substitution of His-43 with tryptophan is predicted to 
inhibit Zn
2+ coordination and therefore the overall function of 
Figure 1.  Mutations of the MARCH5 RING domain induce abnormal 
morphology of mitochondria. MARCH5 structure and the sequence homology 
of RINGv domains of various E3 ubiquitin ligases. The conserved histidine 
43 (red) and cysteines 65 and 68 (blue) that are predicted to affect 
MARCH5 RING ﬁ  nger domain activity were mutated resulting in H43W 
and C65S,C68S mutants (A). Mitochondrial morphology in HeLa cells 
expressing wild type MARCH5-YFP, (green; B), MARCH5
H43W-YFP (green; 
C and D), and MARCH5
C65S,C68S-YFP (green; E) was analyzed by confocal 
microscopy. Mitochondria (red) were revealed by staining for cytochrome c. 
Number of cells with control-like tubular mitochondria, abnormally con-
nected mitochondria, and with mitochondria predominantly localizing in 
perinuclear regions were scored (F). Data represent the average ± SD of 
four transfections per condition with 100 cells counted each time.MARCH5 AND MITOCHONDRIAL FISSION • KARBOWSKI ET AL. 73
the RING domain. Mitochondrial morphology in cells tran-
siently transfected with MARCH5, or MARCH5
H43W expression 
vectors was accessed by confocal microscopy with immuno-
staining of cytochrome c to visualize mitochondria (Fig. 1, B–D). 
As described previously (Yonashiro et al., 2006), overexpres-
sion of wild-type MARCH5 did not affect the overall organiza-
tion of the mitochondrial network in various cell types as 
determined by cytochrome c (Fig. 1, B and F; unpublished data) 
and Tom20 staining patterns (unpublished data). This indicates 
that MARCH5 is well tolerated even at high expression levels 
and appears not to be a rate-limiting factor in mitochondrial 
morphogenesis. However, contrary to previous observations 
  reporting fragmentation of the mitochondrial network as a con-
sequence of MARCH5 inhibition (Nakamura et al., 2006; 
Yonashiro et al., 2006), the majority of cells (52 ± 8.7%) ex-
pressing MARCH5
H43W displayed highly interconnected mito-
chondria (Fig.1, C, D, and F). The aberrant mitochondria range in 
morphology from thin and elongated, often forming tubule nets 
(Fig. 1 C), to highly interconnected thickened tubular and blebbed 
structures (Fig. 1 D). In cells expressing higher amounts of 
MARCH5
H43W a further increase in the diameter and rounding of 
mitochondria was associated with the perinuclear accumulation 
of these organelles (30.5 ± 10%; Fig.1 F; Fig. S1 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200611064/DC1). 
In 17.5 ± 10.4% of MARCH5
H43W-expressing cells, a control-
like organization of the mitochondrial network was observed (Fig. 
1 F). We also constructed another MARCH5 RING mutant by 
replacing cysteines 65 and 68 with serines (MARCH5
C65S,C68S), 
as this mutation has been already shown to inhibit MARCH5 
activity (Yonashiro et al., 2006). Consistent with the effect of 
MARCH5
H43W, expression of MARCH5
C65S,C68S led to the for-
mation of interconnected mitochondria in  63% of cells (Fig. 1, 
E and F). The remaining  31% of cells displayed a perinuclear 
accumulation of mitochondria (Fig. 1 F and Fig. S1 B), or nor-
mal mitochondrial networks (6 ± 2%; Fig. 1 F). The range of 
mitochondrial phenotypes also resembled those induced by 
MARCH5
H43W-YFP. The expression of a MARCH5 construct 
missing the entire RING domain (MARCH5
∆1-71) also led to the 
formation of abnormally interconnected mitochondria, although 
in a smaller percentage of cells (29.7 ± 5.9% cells with abnor-
mally elongated mitochondria and 16.6 ± 8.3% with perinuclear 
clustering of mitochondria; Fig. 1 F; Fig. S1, C and D). These data 
indicate that inactivation of the MARCH5 RING domain induces 
an abnormal interconnection of the mitochondrial network.
MARCH5 RNAi induces 
mitochondrial elongation
To further test the role of MARCH5 in the regulation of mito-
chondrial dynamics, we applied short hairpin RNA interfer-
ence (shRNAi)–mediated down-regulation of MARCH5 protein 
expression. HeLa cells were transfected with control RNAi vec-
tor targeting GFP (control RNAi cells; Lee et al., 2004), or a con-
struct targeting MARCH5 (MARCH5 RNAi cells). As shown 
by Western blot, the MARCH5 RNAi led to a substantial 
down-regulation of MARCH5 expression compared with con-
trol RNAi cells (Fig. 2 A). We also tested the expression levels 
of Mfn2, Drp1, and Fis1, mitochondrial dynamics proteins 
reported to interact with MARCH5 (Nakamura et al., 2006; 
Yonashiro et al., 2006). Whole cell lysates from control RNAi 
and MARCH5 RNAi cells analyzed by Western blot show that a 
reduction of MARCH5 expression was not associated with ap-
parent changes in the protein levels of Mfn2, Drp1, and Fis1 (Fig. 
2 A). To analyze mitochondrial morphology, control RNAi (Fig. 
2 B) and MARCH5 RNAi (Fig. 2 C) cells were immunostained 
for Tom20. In  40% of MARCH5 RNAi cells, mitochondria 
formed elongated and interconnected tubules (Fig. 2, C and D). 
Figure 2.  MARCH5 RNAi-induced abnormal mito-
chondrial interconnection. (A) GFP RNAi or MARCH5 
RNAi cells harvested 9 d after transfection with GFP- 
and MARCH5-silencing vectors were analyzed for 
MARCH5 by Western blot. The expression levels of 
Mfn2, Drp1, and Fis1 proteins implicated in the regula-
tion of mitochondrial dynamics were also tested. Anti-
α-tubulin antibodies were used as a loading control. 
(B–D) Mitochondrial morphology, as revealed by anti-
Tom20 mAbs, in GFP RNAi and MARCH5 RNAi cells 
was analyzed by confocal microscopy. Number of 
cells with control-like tubular mitochondria, abnor-
mally connected, and fragmented mitochondria was 
scored in GFP RNAi and MARCH5 RNAi cells (D). Data 
represent the average ± SD of three transfections per 
condition with 150 cells counted each time.JCB • VOLUME 178 • NUMBER 1 • 2007  74
In contrast to the previous reports, we did not detect a signifi  -
cant fragmentation of mitochondria in MARCH5 RNAi cells 
(5.67 ± 2.31% of MARCH5 RNAi cells, compared with 6.67 ± 
4.72% of control RNAi cells; Fig. 2 D).
Mitochondrial network volume 
and connectivity in cells expressing 
MARCH5 RING domain mutants
To further characterize the effect of MARCH5 activity, we ana-
lyzed mitochondrial network unit size and contiguity using a 
mitochondrial matrix–targeted photoactivable variant of GFP 
(mito-PAGFP) (Karbowski et al., 2004) in cells expressing dif-
ferent MARCH5 constructs. To this end in double-transfected 
cells, 4-μm wide regions of interests (ROIs) (Fig. 3, A and B; 
black squares) were briefl  y irradiated with a 413-nm laser 
followed by imaging with a 488-nm laser immediately after 
413-nm photoactivation (Fig. 3, A and B; middle panels). This 
results in a photoactivation of mito-PAGFP within the ROIs. 
The 488-nm confocal imaging, performed immediately after 
ROI photoactivation, reveals the area of mitochondrial network 
units located within the ROIs and those with matrix compart-
ments contiguous with the ROIs (Karbowski et al., 2004). We 
found that, under the conditions applied here, in control (unpub-
lished data) and wild-type MARCH5-expressing cells (Fig. 3 A) 
the activated mitochondria were usually more restricted to 
the photoactivated ROIs, whereas in MARCH5
H43W (Fig. 3 B) 
and MARCH5
C65S,C68S (unpublished data) expressing cells the 
mito-PAGFP signal redistributes further from the ROIs. This 
indicates an increased size of mitochondrial network units upon 
inhibition of MARCH5 activity. To quantify the relative area 
covered by ROI-activated mitochondria we also photoactivated 
the whole imaging fi  elds. This results in depiction of all the mito-
chondria within the same cells (Fig. 3, A and B; right panels). The 
quantifi  cation of the ratio of area covered by ROI-activated mito-
chondria (r) to that covered by the whole cell mitochondria (w) 
revealed a signifi  cant increase in mitochondrial unit size in 
cells expressing MARCH5
H43W (r/w = 0.595 ± 0.179) and 
MARCH5
C65S,C68S (r/w = 0.626 ± 0.199), compared with control 
(r/w = 0.243 ± 0.086) and wild-type MARCH5 (r/w = 0.240 ± 
0.074) expressing cells (Fig. 3 C).
To analyze mitochondrial network complexity, we also 
applied FRAP, as described previously (Szabadkai et al., 2004; 
Karbowski et al., 2006), in cells expressing MARCH5-CFP, 
MARCH5
H43W-CFP, or MARCH5
C65S,C68S-CFP together with a 
mitochondrial matrix–targeted yellow fl  uorescent protein (mito-
YFP). To measure FRAP, 3-μm ROIs (Fig. 3, D and E; red circles) 
in double-transfected cells were photobleached to  50% of 
the initial mito-YFP fl  uorescence by irradiating with a high 
power laser. This was followed by the analysis of the YFP fl  uor-
escence recovery every 400 msec for  14 s. Under conditions 
in which mito-YFP fl  uorescence in control cells recovered to 
65.35 ± 7.6% of prebleach fl  uorescence, as accessed at the 
last time points of each measurement, fl  uorescence recoveries 
in MARCH5
H43W and MARCH5
C65S,C68S-expressing cells were 
signifi  cantly higher (Fig. 3 F; 76.3 ± 9.74 and 76.1 ± 7.02, 
respectively). Confi  rming the immunofl  uorescence results (Fig. 
1, B and F), mito-PAGFP analysis (Fig. 3, A–C), and published 
data (Yonashiro et al., 2006), there was no statistically sig-
nifi  cant difference in FRAP between control and wild-type 
MARCH5-expressing cells (Fig. 3 F; 68.22 ± 9.22, P > 0.2). 
This demonstrates that ectopic expression of wild-type MARCH5 
does not affect the overall volume of mitochondria, whereas the 
increased FRAP in the MARCH5 RING mutant–expressing 
cells refl  ects increased mitochondrial connectivity. We also per-
formed control FRAP experiments in cells expressing Drp1
K38A, 
a dominant-negative mutant of mitochondrial fi  ssion protein 
Drp1, or in cells transfected with the viral mitochondria-associated 
inhibitor of apoptosis (vMIA) (Fig. 3 F). It has been shown that 
Drp1
K38A induces aberrant mitochondrial elongation (Smirnova 
et al., 2001), whereas vMIA causes mitochondrial fragmentation 
(McCormick et al., 2003; Karbowski et al., 2006). There was 
a signifi  cant increase of FRAP in Drp1
K38A-expressing cells 
(Fig. 3 F; 80.2 ± 9.24), and a decrease in vMIA-expressing 
cells (Fig. 3 F; 54.03 ± 6.89). There was no signifi  cant dif-
ference between mitochondrial FRAP values in cells express-
ing MARCH5 RING mutants and Drp1
K38A (MARCH5
H43W/
Drp1
K38A, P > 0.1; and MARCH5
C65S,C68S/Drp1
K38A, P > 0.1), 
leading to the conclusion that MARCH5 RING domain mutation-
induced mitochondrial defects are qualitatively and quantita-
tively comparable to those induced by Drp1
K38A, an established 
inhibitor of mitochondrial division (see also Supplemental text 
and Fig. S2 and Fig. S3, available at http://www.jcb.org/cgi/
content/full/jcb.200611064/DC1).
Our observations appear to contradict recently pub-
lished interpretations of mitochondrial phenotypes in MARCH5 
RING domain mutant    –expressing cells (Nakamura et al., 2006; 
Yonashiro et al., 2006). It has been reported that mitochondrial 
fragmentation, but not elongation, is a predominant response 
to inhibition of MARCH5 activity. We found that in all cases 
analyzed here, after expression of: (1) N- and C-terminal YFP 
fusion of MARCH5
H43W; and (2) C-terminal fusions of 
MARCH5
C65S,C68S and MARCH5
∆1-71 (Fig. S2 A), as well as 
Myc-tagged MARCH5
H43W (Fig. S2 B), normal morphology 
or an abnormal elongation and connection of mitochondria 
prevail in cells expressing low to moderate levels of the mutant 
proteins. One explanation is that the enlarged and rounded 
perinuclear mitochondria that are more apparent in cells pro-
ducing high levels of MARCH
5H43W, MARCH5
C65S,C68S, and 
MARCH5
∆1-71 could be interpreted as “fragmented” at low 
magnifi  cation (Fig. S1, A–C). Yet, when compared with small 
vesicular mitochondria formed as a result of unbalanced divi-
sion when mitochondrial fusion is impaired in Opa1 RNAi 
cells (Fig. S3 A) or Mfn1KO and Mfn2KO mouse embryonic 
fi  broblasts (MEFs) (see Fig. 7), the round perinuclear organ-
elles in MARCH5 mutant–expressing cells are much larger 
(Fig. S3 B). Furthermore, expression of the MARCH5 RING 
mutants does not cause an obvious increase in mitochondrial 
number (Fig. S3, A and B; unpublished data), expected upon 
activation of mitochondrial division, suggesting that mitochon-
drial fi  ssion does not cause the MARCH5 inhibition-induced 
mitochondrial aberrations. In fact, it has been demonstrated, 
both in mammalian cells (Smirnova et al., 2001) and in yeast 
(Griffi  n et al., 2005), that strong fi  ssion   defects can lead to 
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whereas lesser inhibition of this process induces the formation 
of spread, net-like mitochondria. Taking into consideration 
that only relatively high levels of MARCH5 mutant expres-
sion can stimulate perinuclear collapse and rounding of mito-
chondria (unpublished data), one can picture that the degree 
of fi  ssion in MARCH5
H43W or MARCH5
C65S,C68S transfected 
cells is inversely proportional to the expression levels of the 
mutant proteins, as expected to occur in the case of dominant-
negative mutants. As a consequence of this relation, in the most 
extreme cases mitochondrial alterations comparable to those 
induced by “strong” dominant-negative mutants of Drp1 may 
take place (Smirnova et al., 2001). We therefore attempted 
to test whether round collapsed mitochondria in MARCH5 
mutant–expressing cells are separate units or whether they form 
aberrant but interconnected mitochondrial networks. To attain 
this we used another FRAP-based approach (Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200611064/DC1). 
Multiple cycles of bleach (marked with “V” in Fig. S4, B–D) 
and fl  uorescence recovery were applied to seemingly separate 
round mitochondria (ROI 1 in Fig. S4 A; bleached area diameter 
 2 μm), while avoiding direct photobleaching of the adja-
cent mitochondria. Changes of fl  uorescence intensities of the 
photobleached ROI 1 (Fig. S4 B), a directly adjacent mito-
chondrion (ROI 2; Fig. S4 C), and a mitochondrion located 
relatively far from the bleached area (ROI 3; Fig. S4 D) were 
plotted as a function of time. We found that effi  cient fl  uores-
cence recoveries in ROI 1 occur after each bleach that were 
  associated with a gradual depletion, but also slightly delayed 
fl  uorescence recovery in ROI 2 and little change in ROI 3. 
From these data we can conclude that an exchange of mito-
YFP occurs between ROI 1 and ROI 2, and that the mitochon-
drion in ROI 3 is separate from ROIs 1 and 2. Moreover, 
because the mitochondrion located in ROI 2 also recovers 
mito-YFP fl  uorescence, it most likely is also connected with 
another mitochondria. Because mitochondrial   matrix–targeted 
GFP can diffuse freely with the rate of 15–19 msec (Partikian 
et al., 1998) in normal tubular mitochondria in HeLa cells, the 
delayed response of ROI 2 indicates that it is likely connected 
with a mitochondrion located within ROI 1 by abnormally thin 
mitochondrial tubules. This is consistent with the observations 
that seemingly separate, round mitochondria visible in Dnm1p 
mutant Caenorhabditis elegans are able to exchange matrix-
targeted GFP (Labrousse et al., 1999). In sum, based on the 
data discussed above, we conclude that in cells expressing 
MARCH5
H43W and MARCH5
C65S,C68S an abnormal intercon-
nection of mitochondria is the main morphological manifes-
tation and that inhibition of MARCH5 activity increases the 
volume and decreases the number of mitochondrial units 
within the network. This points to a possible inhibition of 
mitochondrial fi  ssion or activation of fusion by the loss of 
MARCH5 activity.
Figure 3. Quantiﬁ  cation of mitochondrial volume and connectivity in cells 
expressing MARCH5 RING mutants. The mito-PAGFP diffusion-based as-
say (A–C) and FRAP (D–F) were used to investigate the relative size of 
mitochondrial network units in wild-type MARCH5 and MARCH5 RING 
mutant–expressing cells. For the mito-PAGFP based mitochondrial inter-
connectivity assay, cells were cotransfected with CFP-tagged WT 
MARCH5 (A and C), MARCH5
H43W (B and C), MARCH5
C65S,C68S (C) to-
gether with mito-PAGFP or transfected with mito-PAGFP alone (C). The 
pseudocolored images of typical cells expressing wild-type MARCH5 (A) 
and MARCH5
H43W (B) are shown. The degree of mitochondrial inter  con-
nectivity was quantiﬁ  ed using MetaMorph image analysis software (C). 
Red bars show averages ± SD of 17 measurements per experimental 
group, as indicated. Black diamonds represent values obtained from each 
single cell measurement (C). HeLa cells transiently cotransfected with CFP-
tagged WT MARCH5, MARCH5
H43W, MARCH5
C65S,C68S-YFP together with 
mito-YFP or transfected with mito-YFP alone were assayed by FRAP for mito-
chondrial volume. The typical control, mito-YFP expressing cell (D), and 
cell expressing MARCH5
H43W and mito-YFP (E) used in FRAP experiments 
are shown before and directly after photobleaching of regions of interest 
indicated with red rings. FRAP curves obtained after averaging of 19 single 
cell analysis per group, as well as the degree of FRAP in the indicated ex-
perimental groups are shown in F.JCB • VOLUME 178 • NUMBER 1 • 2007  76
Submitochondrial coalescence of MARCH5 
RING domain mutants
During the analysis of mitochondrial morphology in wild-type 
MARCH5-YFP, MARCH5
H43W-YFP, and MARCH5
C65S,C68S-
YFP expressing cells we noticed that while wild-type MARCH5 
decorated mitochondria uniformly (Fig. 1 B), MARCH5
H43W 
(Fig. 1, C and D; Fig. 4 A) and MARCH5
C65S,C68S (Fig. 1 E) 
localized mainly to submitochondrial aggregates with some 
diffusely circumscribing the OMM. To quantify the degree 
of MARCH5 association with the OMM, cells were trans-
fected with wild-type MARCH5-YFP, MARCH5
H43W-YFP, or 
MARCH5
C65S,C68S-YFP followed by immunostaining for Tom20 
and confocal image acquisition (Fig. 4 A). The quantifi  cation 
of the colocalization of green channel pixels (MARCH5 and 
MARCH5 RING mutants) with red channel pixels (Tom20) 
was performed using the “colocalization” function of the image 
analysis software Volocity. The association degree of different 
variants of MARCH5 with the OMM is depicted as a Pearson’s 
Correlation coeffi  cient (r) (Fig. 4 B) where the r-values between 
−0.3 ± 0.3 indicate little or no association, +0.3 ± 0.7 weak 
positive association, and +0.7 ± 1.0 strong positive association. 
Using this analysis we found that MARCH5-YFP, which local-
izes to the OMM in a diffuse manner with only occasional submi-
tochondrial coalescence and extramitochondrial localization, 
shows a high degree of association with the OMM (r = 0.77 ± 
0.03; Fig. 4 B). MARCH5
H43W-YFP (r = 0.46 ± 0.11; Fig. 4, 
A and B) and MARCH5
C65S,C68S-YFP (r = 0.36 ± 0.09; Fig. 
4 B) display a distinctly lower degree of association with the 
OMM, indicating that mutations perturbing the activity of the 
MARCH5 RING domain lead to a redistribution of this pro-
tein in the OMM.
Next, we studied whether inhibition of the MARCH5 
RING domain may affect oligomerization of this protein that 
may contribute to the focal appearance on mitochondria. To 
achieve this, mitochondria-enriched heavy membrane frac-
tions (HM) were treated with the chemical cross-linker Bis-
Maleimidohexane (BMH) and analyzed by Western blot for 
Myc-tagged MARCH5 (Fig. 4 C). We found, in contrast to 
wild-type MARCH5, which was mostly detected as a 33-kD 
monomer and an  65-kD form, that MARCH5
H43W also formed 
higher molecular weight complexes. The  65-kD form of 
MARCH5 most likely represents homodimers of this protein 
(Fig. S4). The molecular components of the high molecular 
weight complexes containing the MARCH5 RING mutant are 
currently unknown. However, most likely these structures con-
tribute to the formation of MARCH5 RING mutant submito-
chondrial foci. This difference in submitochondrial localization 
and oligomerization of the MARCH5 RING mutants compared 
with the wild-type protein suggests that protein complexes con-
taining inactive MARCH5 and its substrates are stabilized and/
or abnormally enlarged, likely due to perturbed ubiquitylation.
MARCH5 RING domain mutations 
lead to abnormal mitochondrial assembly 
of the ﬁ  ssion protein Drp1
We investigated whether certain OMM-associated proteins, 
including those participating in mitochondrial morphogenesis, 
also accumulate in MARCH5
H43W- and MARCH5
C65S,C68S-
enriched mitochondrial aggregates. Cells transfected with 
MARCH5-YFP and MARCH5
H43W-YFP, in the presence or 
absence of cotransfection with mammalian expression vectors 
encoding Myc-tagged integral membrane proteins of the OMM, 
OMP25 and Fis1, were immunostained with anti-Myc anti-
bodies or antibodies detecting endogenous Tom20, Tom22, endo-
philin B1, and Drp1. Although changes in the distribution of 
Tom20 (Fig. 4 A), Tom22, OMP25 and endophilin B1, as well 
as YFP-tagged mitochondrial fusion proteins Mfn1 and Mfn2 
Figure 4.  Submitochondrial coalescence of MARCH5 RING mutants. 
HeLa cells expressing wild-type MARCH5-YFP, MARCH5
H43W-YFP, and 
MARCH5
C65S,C68S-YFP were immunostained for Tom20, and analyzed by 
confocal microscopy. An example of a cell expressing MARCH5
H43W-YFP 
(green) and immunostained for Tom20 (red) that was used for the analysis 
is shown in A. The colocalization degree of Tom20 with MARCH5 pro-
teins was performed using the image analysis software Volocity (B). The 
values shown in B represent Pearson’s Correlation units (r) that reveal 
the degree of association of pixels in different channels of the confocal 
image. (C) The oligomeric states of Myc-tagged wild-type MARCH5 and 
MARCH5
H43W were analyzed by Western blot in cells treated with the 
chemical cross-linker BMH or with the solvent DMSO. Mitochondria-
enriched heavy membrane fractions (HM) were subjected to SDS-PAGE 
and Western blot analysis. MARCH5 was detected with anti-Myc mAbs. 
The loading was controlled with anti Hsp60 mAbs. Asterisk represents 
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were not noticeable (unpublished data), an abnormal localiza-
tion pattern of the fi  ssion protein Drp1 was apparent (Fig. 5, A–B′). 
In the most extreme cases, occurring in cells with a high degree of 
MARCH5
H43W-YFP expression, formation of extremely enlarged 
perinuclear clusters of Drp1 was observed (Fig. S5 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200611064/DC1). 
Consistent with MARCH5
H43W, expression of MARCH5
C65S,C68S-
YFP also induced abnormal mitochondrial clustering of Drp1 
(Fig. 5, C and C′). Furthermore, confocal analysis (Fig. 5, B–C′) 
and quantifi  cation of Pearson’s Correlation values (Fig. 5 D) 
of cells expressing MARCH5
H43W-YFP or MARCH5
C65S,C68S-
YFP and stained for Drp1 revealed clear colocalization of these 
Figure 5.  Drp1 colocalizes with mitochondrial complexes of MARCH5 RING mutants. Cells transfected with MARCH5-YFP (A; green), MARCH5
H43W-
YFP (B; green) and MARCH5
C65S,C68S-YFP (C; green) were immunostained for Drp1 (red) and analyzed by confocal microscopy. The inserts in A–C show 
magniﬁ  ed fragments (white squares) of the respective cells. Relative ﬂ  uorescence intensities of Drp1 (red lines) and MARCH5 variants (green lines) 
located in cell areas indicated in the respective images were measured using Zeiss LSM510 software (A′–C′). Note the high degree of the MARCH5 
and Drp1 linescan overlap in MARCH5 RING mutant–expressing cells. The overall degree of Drp1 colocalization with different variants of MARCH5 
was analyzed using the colocalization function of Volocity software (D). Values shown represent Pearson’s Correlation units (see text). Drp1 RNAi (E, F, 
and H) and control RNAi (G and H) cells obtained as described previously (Lee et al., 2004), were transfected with MARCH5-YFP (E and H) and 
MARCH5
H43W-YFP (F–H), immunostained for Tom20 to reveal the OMM (red in overlay images) and analyzed by confocal microscopy. The bottom pan-
els in E and F show magniﬁ  ed fragments of cells indicated by red squares. Arrows indicate peroxisomes, arrowheads mitochondria. The association of 
MARCH5 and MARCH5
H43W with Tom20 in control RNAi and Drp1 RNAi cells was quantiﬁ  ed (H). The degrees of association are shown as Pearson’s 
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proteins (Fig. 5 D), suggesting that MARCH5 participates in 
the regulation of Drp1. However, the fi  ssion protein Fis1 (Yoon 
et al., 2003; Stojanovski et al., 2004) did not localize to these 
MARCH5/Drp1-positive structures (Fig. S5 B). Because yeast 
Fis1p is required to recruit Dnm1p early during mitochondrial 
scission (Shaw and Nunnari, 2002), MARCH5 could be in-
volved in mitochondrial scission downstream of human Fis1.
Membrane translocation of the Drp1 homologue, dynamin, 
and dynamin-mediated endocytic vesicle scission are regulated 
by binding and hydrolysis of GTP (Hinshaw, 2000; Praefcke and 
McMahon, 2004). Therefore, we tested whether Drp1 colocal-
ization with MARCH5 depends on Drp1 GTPase activity. 
Cells were cotransfected with MARCH5
H43W-YFP and GTPase-
inactive Drp1
K38A, immunostained for Drp1 and analyzed by 
confocal microscopy. As shown before (Yoon et al., 2001), un-
like overexpressed wild-type Drp1 that correctly localizes to 
small submitochondrial foci (Smirnova et al., 2001; Karbowski 
et al., 2002), Drp1
K38A forms enlarged aggregates that are only 
partly associated with mitochondria. We found that these Drp1
K38A 
containing structures do not colocalize with MARCH5
H43W-YFP 
(Fig. S5 C), whereas overexpressed wild-type Drp1 does 
(unpublished data). This suggests that the GTPase activity of 
Drp1 is required for its translocation to MARCH5
H43W-YFP–
  enriched complexes on the OMM. Interestingly, there was no 
detectable effect of Drp1
K38A on the submitochondrial localization 
of wild-type MARCH5-YFP and MARCH5
H43W-YFP. In contrast, 
knockdown of Drp1 expression resulted in the redistribution 
of MARCH5
H43W-YFP from foci (Fig. 5 G) into a more diffuse 
mitochondrial localization (Fig. 5, E and F) that colocalized 
with Tom20 to a signifi  cantly greater extent than when ex-
pressed in control RNAi cells (Fig. 5 H). This demonstrates that 
MARCH5
H43W-YFP clusters are to some extent Drp1 dependent. 
However, MARCH5 RNAi did not induce abnormal distribution 
of Drp1, as revealed by immunofl  uorescence and Western blot 
(unpublished data). Collectively, these data suggest a functional 
interdependence between MARCH5 and Drp1.
MARCH5 RING domain mutants stabilize 
mitochondrial ﬁ  ssion complexes
The data showing that expression of MARCH5
H43W or 
MARCH5
C65S,C68S has a strong impact on the localization of 
Drp1, and that Drp1 expression impacts MARCH5
H43W distri-
bution, suggest that MARCH5 is involved in the regulation 
of the mitochondrial fi  ssion complexes. The abnormal orga-
nization of Drp1 on mitochondria in MARCH5
H43W and 
MARCH5
C65S,C68S, but not wild-type MARCH5-expressing cells 
(Fig. 5, A–D), suggests that the transition between certain mito-
chondrial steps of the Drp1-dependent fi  ssion cycle is blocked 
by the inhibition of MARCH5 activity. In mammalian cells as 
well as in yeast, Drp1/Dnm1p cycles between the cytosol and 
mitochondria (Smirnova et al., 2001; Legesse-Miller et al., 
2003). It is possible that the formation of abnormal fi  ssion com-
plexes in response to the expression of MARCH5 mutants is 
caused by changes in the subcellular dynamics of Drp1. To test 
this hypothesis, the mobility of YFP-Drp1 in cells expressing 
MARCH5-CFP, MARCH5
H43W-CFP, and MARCH5
C65S,C68S-
CFP (MARCH5/Drp1 plasmid ratio 5:1) or in control cells was 
analyzed by FRAP (Fig. 6 A). We confi  rmed that, like endoge-
nous Drp1 (Fig. 5 A), the subcellular localization of YFP-Drp1 
is altered by the expression of MARCH5 RING mutants and 
that the YFP tag does not infl  uence colocalization of these pro-
teins (unpublished data). To measure FRAP, a 4-μm strip 
through YFP-Drp1–expressing cells was photobleached by ir-
radiation with a high power laser and subsequent fl  uorescence 
recovery was monitored over  20 s. The recovery curves were 
normalized, with the last time point values of the fastest recov-
ering wild-type MARCH5 taken as 100%, and immediate post-
bleach values of each sample (1.06 s postbleach) as 0%. As 
shown in Fig. 6 A, a distinct decline in the mobility of assem-
bled complexes of YFP-Drp1 in cells expressing MARCH5
H43W 
or MARCH5
C65S,C68S compared with YFP-Drp1, or Drp1 and 
wild-type MARCH5 cotransfected cells was evident.
We also tested the effects of MARCH5 activity on the 
expression level, mitochondrial association (Fig. 6 B), and the 
oligomerization (Fig. 6 C) of endogenous Drp1. Whole cell 
lysates (WCL) and heavy membrane (HM) fractions obtained 
from HeLa cells expressing Myc-tagged, wild-type MARCH5 
or MARCH5
H43W were analyzed by Western blot (Fig. 6 B). The 
data show that, while the total expression level of Drp1 is not 
infl  uenced by MARCH5 RING domain activity, the quantity of 
Drp1 associating with mitochondria is slightly increased in 
MARCH5
H43W-expressing cells and, to a lesser degree, in cells 
expressing wild-type MARCH5 (Fig. 6 B). The WCL and HM 
fractions used in these analyses were obtained. Thus, one can 
conclude that the MARCH5 RING mutants affect the cellular 
dynamics of Drp1, but not the degradation of this protein (see 
also Fig. 2 A). Next, to reveal the oligomeric state of mito-
chondria-associated Drp1, aliquots of the HM fractions were 
also treated with BMH (Fig. 6 C). Using this approach, we did 
not detect any clear alterations in the Drp1 oligomerization. 
These data suggest that the organization of the subunits forming 
the light microscopy-detectable Drp1 complexes is not infl  u-
enced by MARCH5 activity.
In sum, we conclude that the cellular mobility of Drp1, 
but not proteasome-dependent degradation of this protein is 
regulated by MARCH5 activity.
MARCH5 RING mutants reverse 
mitochondrial defects in Mfn1 and Mfn2 
knock-out cells
It has been reported that in addition to Drp1 and Fis1 (Nakamura 
et al., 2006; Yonashiro et al., 2006), proteins required for mito-
chondrial division, MARCH5 also coimmunoprecipitates with 
Mfn2 (Nakamura et al., 2006), a mitochondrial fusion protein. 
Therefore, we analyzed the effect of wild-type MARCH5 and 
MARCH5
H43W expression on the proteasome-dependent degra-
dation of Mfn2 (Fig. 7 A). To inhibit a proteasome-dependent 
degradation of Mfn2, cells were treated with the proteasome 
inhibitor MG132. Mitochondria-enriched HM fractions were 
obtained from MG132-treated or untreated HeLa cells express-
ing Myc-tagged, wild-type MARCH5 or MARCH5
H43W. Although 
proteasomal activity is required for Mfn2 degradation, MARCH5 
does not infl  uence Mfn2 levels in either MG132-treated or un-
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The relative contribution of MARCH5 to mitochondrial 
division and fusion is not known. By analyzing whether wild-
type MARCH5 and MARCH5 RING mutants can complement 
mitochondrial defects in Mfn1 (Mfn1KO) and Mfn2 (Mfn2KO) 
knock-out MEFs, we tested the degree to which MARCH5 
 activity  infl  uences mitochondrial fi  ssion versus fusion. It has 
been shown that the abnormally fragmented mitochondria in 
Mfn1KO and Mfn2KO MEFs are formed as a result of reduced 
fusion and unrestrained fi  ssion of these organelles (Chen et al., 
2003). The ectopic expression of Drp1
K38A, a strong inhibitor of 
mitochondrial division, reverses the mitochondrial defects in 
Mfn1KO and Mfn2KO cells (Chen et al., 2003). This indicates 
that the residual fusion of mitochondria in these cells is suffi  -
cient to rebuild tubular mitochondria. We found that, in contrast 
to wild-type MARCH5 (Fig. 7, B and E), when expressed in 
Mfn1KO or Mfn2KO cells, both MARCH5
H43W (Fig. 7, C–E) 
Figure 6.  MARCH5 RING mutations decrease cellular mobility of Drp1. 
HeLa cells transiently transfected with YFP-Drp1 with or without cotransfec-
tion with MARCH5-CFP, MARCH5
H43W-CFP, and MARCH5
C65S,C68S-CFP 
were analyzed for cellular mobility of Drp1 with the FRAP assay (A). The 
averaged recovery curves and the FRAP values quantiﬁ  ed at 1.73 s and 
19.66 s after photobleach in the indicated experimental groups are shown 
at the bottom (A). The degree of Drp1 association with mitochondria was 
analyzed by Western blot (B). The whole cell lysate (WCL) and mitochondria-
enriched heavy membrane (HM) fractions were obtained from HeLa cells 
transfected with Myc-tagged, wild-type MARCH5 and MARCH5
H43W. Pro-
teins were resolved using SDS-PAGE and then immunostained for Drp1. 
The loading was controlled with anti-Hsp60 antibodies. The HM fractions 
obtained from cells expressing Myc-tagged, wild-type MARCH5, and 
MARCH5
H43W were also treated with a chemical cross-linker BMH, or with 
solvent DMSO. The samples were analyzed by Western blot for Drp1 (C).
Figure 7.  Expression of MARCH5 RING mutants restores tubular mito-
chondria in Mfn1KO and Mfn2KO cells. (A) Expression levels of endoge-
nous Mfn2 in wild-type MARCH5 and MARCH5
H43W-expressing cells was 
analyzed by Western blot. The whole cell lysate (WCL) and mitochondria-
enriched heavy membrane (HM) fractions were obtained from HeLa cells 
incubated in the presence and absence of MG132 and transfected with 
Myc-tagged MARCH5 and MARCH5
H43W. Proteins were resolved using 
SDS-PAGE and then immunostained with anti-Mfn2 polyclonal antibodies. 
The loading was controlled by immunostaining with anti-Hsp60 antibodies. 
Mfn2KO cells transfected with MARCH5-YFP (B; yellow on overlay image) 
or MARCH5
H43W-YFP (C and D; green on overlay images) were stained 
with anti-cytochrome c mAbs to reveal mitochondria (red on overlay im-
ages) and analyzed by confocal microscopy. In E, cells were scored for the 
morphology of mitochondria. Data represent averages ± SD of three trans-
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and MARCH5
C65S,C68S (Fig. 7 E) distinctly reversed mitochon-
drial fragmentation, inducing the formation of normal reticular 
mitochondria (Fig. 7, C and E) or, in the most extreme cases, in-
duced abnormally interconnected organelles (Fig. 7, D and E). 
The MARCH5 RING mutant–induced reconstitution of reticu-
lar mitochondria in Mfn1KO and Mfn2KO cells indicates that 
the activity of the MARCH5 RING domain is a strong determi-
nant of mitochondrial membrane dynamics.
Because MARCH5 coimmunoprecipitates with the mito-
chondrial fusion protein Mfn2 (Nakamura et al., 2006), it is pos-
sible that, due to a partial functional redundancy between Mfn1 
and Mfn2 (Chen et al., 2003), MARCH5 RING mutants may 
stimulate the activity of Mfn2 in Mfn1KO cells, and Mfn1 activ-
ity in Mfn2KO cells. Therefore, we tested the relative contribu-
tion of mitochondrial fusion to the MARCH5 RING mutant–
induced elongation of Mfn2KO cell mitochondria (Fig. 8). We 
measured mitochondrial fusion in control Mfn2KO cells (Fig. 8, 
A and D), and in Mfn2KO cells expressing MARCH5
H43W (Fig. 8, 
C and D) using a mito-PAGFP-dilution–based assay (Karbowski 
et al., 2004). As a positive control we used Mfn2KO cells ec-
topically expressing Mfn2 (Fig. 8, B and D). The relative rates 
of mitochondrial fusion were quantifi  ed at different time points 
after ROI photoactivation, as indicated (Fig. 8). At 45 min after 
ROI photoactivation, mito-PAGFP fl  uorescence dilution in 
Mfn2KO MEFs was dramatically increased by ectopic expres-
sion of Mfn2 (Fig. 8, A, B, and D; ∆mito-PAGFP fl  uorescence  28.5% 
in Mfn2KO MEFs, compared with ∆mito-PAGFP fl  uorescence  76% in 
Mfn2KO MEFs expressing Mfn2; P = 1.176 × 10
−18). These 
data indicate that the mitochondrial fusion in Mfn2KO cells was 
reconstituted by the reexpression of Mfn2. In contrast, mito-
chondrial fusion in Mfn2KO MEFs was only slightly improved 
by the expression of MARCH5
H43W (Fig. 8, A, C, and D; at 
45 min after photoactivation ∆mito-PAGFP fl  uorescence   39.7% in 
Mfn2KO MEFs expressing MARCH5
H43W; P = 0.026). These 
MARCH5
H43W-induced improvements of mitochondrial fusion 
in Mfn2KO MEFs suggest that to some degree mitochondrial 
fusion could be regulated by MARCH5 activity. However, we 
found that there is no additional affect of MARCH5 RING 
mutants on mitochondrial morphology in Drp1 RNAi cells 
(Fig. 5 F), whereas overexpression of Mfn2 dramatically elon-
gates mitochondria in Drp1 activity-defi  cient cells (Santel and 
Fuller, 2001). Thus, one can conclude that MARCH5 RING 
mutants reconstitute tubular mitochondria in Mfn1KO MEFs 
and Mfn2KO MEFs mainly through their inhibition of mito-
chondrial fi  ssion.
Ectopic expression of Drp1 compensates 
for MARCH5 RING domain mutation–
induced mitochondrial defects
Altogether, the data presented above suggest that the abnor-
mal mitochondrial interconnection in MARCH5
H43W or 
MARCH5
C65S,C68S expressing cells is due to an inhibition of 
Drp1-dependent mitochondrial fi  ssion. Therefore, we tested 
whether the ectopic expression of Drp1 could reverse this mito-
chondrial phenotype. Cells were cotransfected with MARCH5 
(Fig. 9 C) or MARCH5 RING mutants (Fig. 9, A– C; green on 
overlay images) as well as Drp1 (MARCH5/Drp1 molar ratio 1:5), 
followed by immunostaining for Drp1 (red on overlay images) 
and Tom20 (blue on overlay images), to reveal mitochondrial 
morphology. Cells expressing elevated levels of Drp1 together 
with different variants of MARCH5 (Fig. 9, A and B, labeled 
with asterisk) were scored for mitochondrial morphology 
(Fig. 9 C). We found a substantial reversal of the aberrant mito-
chondrial phenotypes in cells cotransfected with MARCH5 
mutants and Drp1. In 64.25% of the cells expressing 
MARCH5
H43W and 65.5% of cells expressing MARCH5
C65S,C68S 
together with elevated levels of Drp1, mitochondrial network 
organi  zation resembled that of control cells. The overexpression 
of Drp1 alone only slightly affected mitochondrial structure 
Figure 8.  Effect of MARCH5
H43W on mitochondrial fusion rates in Mfn2KO 
cells. Mitochondrial fusion in Mfn2KO MEFs (A and D), Mfn2KO MEFs ec-
topically expressing Mfn2 (B and D), or MARCH5
H43W-CFP (C and D) was 
analyzed using mito-PAGFP dilution based assay. Details of the cell areas 
containing photoactivated mito-PAGFP (red squares) are shown below the 
respective images. The images of cells before photoactivation were ob-
tained with the higher detector gain. The dilution rates of mito-PAGFP over 
the time of the experiment were quantiﬁ  ed (D). Data was normalized, with 
the mito-PAGFP ﬂ  uorescence at 30 s after photoactivation used as 100%. 
Data represent averages ± SD of 62 (Mfn2KO cells), 53 (Mfn2KO cells 
expressing MARCH5
H43W), and 32 (Mfn2KO cells ectopically expressing 
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(Fig. 9 C), inducing mitochondrial fragmentation in <10% of 
the cells. This indicates that ectopic expression of Drp1 specifi  -
cally compensates for the MARCH5 RING mutant–induced 
alterations of mitochondria and suggests further that MARCH5 
RING mutants may compete with Drp1 for certain factors in-
volved in mitochondrial fi  ssion. Because expression of the mito-
chondrial fi  ssion protein Fis1 (Yoon et al., 2003; Stojanovski 
et al., 2004) does not reverse mitochondrial alterations induced 
by expression of MARCH5 RING mutants (unpublished data; 
Fig. 5 E) we conclude that MARCH5 regulates mitochondrial 
fi  ssion downstream of Fis1. This conclusion is also supported 
by the fact that expression of MARCH5 RING mutants had 
no detectable impact on the submitochondrial distribution of 
Fis1 (Fig. S5 B).
Discussion
The data described in this study indicate that MARCH5, an 
integral ubiquitin E3 ligase of the OMM, is required for mito-
chondrial division in mammalian cells. This conclusion is based 
on the following evidence: (1) Expression of MARCH5 RING 
mutants induces abnormal interconnection of mitochondria, as 
well as an increase in size, and decrease in the number of mito-
chondrial network units. (2) MARCH5 RNAi induces mito-
chondrial elongation. (3) The subcellular distribution and 
mitochondrial association of Drp1, a protein essential for mito-
chondrial division, is signifi  cantly  infl   uenced by MARCH5 
RING domain activity and the localization of MARCH5 RING 
mutants on mitochondria is altered by knockdown of Drp1 
expression. Moreover, MARCH5 RING mutants colocalize with 
Drp1-enriched mitochondrial foci. (4) Ectopic expression of 
Drp1 reverses the MARCH5 RING mutant–induced mitochon-
drial abnormalities, suggesting strong functional interdepen-
dence of MARCH5 and Drp1. (5) MARCH5 RING mutants 
reverse mitochondria defects in Mfn1KO and Mfn2KO MEFs, 
most likely through the inhibition of mitochondrial division.
The data showing the formation of abnormally enlarged 
clusters of Drp1, mitochondrial accumulation of Drp1, as well 
as an inhibition of Drp1 mobility in MARCH5 RING mutant–
expressing cells support the hypothesis that MARCH5 is a 
positive regulator of mitochondrial division. Since it has been 
reported before that MARCH5 can be coimmunoprecipitated 
only with the ubiquitylated form of Drp1 (Nakamura et al., 
2006), the mitochondrial scission complexes are likely regulated 
by MARCH5-mediated conjugation of ubiquitin. Consistent 
with this, a reduction of MARCH5 ubiquitin ligase activity ap-
parent after expression of MARCH5 RING mutants or by RNAi 
leads to major defects in mitochondrial division. The opposite 
phenotype, mitochondrial fragmentation, could be expected to 
occur if MARCH5 mediated degradation of Drp1, Fis1, or any 
positive regulator of mitochondrial division. The data showing 
no clear effect of the MARCH5 activity on the degradation of 
Drp1 or Mfn2, as well as the rescue of the fragmented mito-
chondria in Mfn1KO and Mfn2KO MEFs by MARCH5 RING 
mutants, support the model of a “molecular switch”. In this sce-
nario, MARCH5 could be essential for the activity of mitochon-
drial fi  ssion complexes, for example by affecting Drp1 GTPase 
activity or infl  uencing protein interactions within the mitochon-
drial fi  ssion machinery. Increased colocalization of MARCH5 
RING mutants and Drp1, as well as abnormal mitochondrial as-
sociation of Drp1 that could occur due to inhibition or delay of 
a specifi  c step of the fi  ssion reaction, perhaps via perturbed 
ubiquitylation of an essential fi  ssion protein, further support this 
hypothesis. Yet, it cannot be excluded that MARCH5 regulates 
the stability of a currently unknown protein repressor of mito-
chondrial fi  ssion. The abnormal accumulation of such a factor in 
MARCH5 RING mutant–expressing cells could lead to the inhi-
bition of fi  ssion complexes and elongation of mitochondria.
Figure 9.  Ectopic expression of Drp1 reverses MARCH5 
mutation-induced mitochondrial morphology defects. HeLa 
cells were transiently transfected with MARCH5-YFP, 
MARCH5
H43W-YFP (A; green), and MARCH5
C65S,C68S-YFP 
(B; green) in the presence of cotransfection with Drp1 
and then immunostained with anti-Tom20 polyclonal an-
tibodies (A and B; blue) and with anti-Drp1 mAbs (A and 
B; red). Asterisk represents the transfected cell in the 
ﬁ  eld. Cells were scored for the morphology of mitochon-
dria. Data represent averages ± SD of four transfections 
with 100 cells counted each time (C).JCB • VOLUME 178 • NUMBER 1 • 2007  82
It has been proposed that conjugation of the ubiquitin-like 
molecule SUMO-1 stabilizes Drp1 in mammalian cells (Harder 
et al., 2004), especially in the context of apoptosis induction 
(Wasiak et al., 2007). This implies that conjugation of SUMO-1 
could be the main determinant of Drp1traffi  cking onto or off 
mitochondria, however participation of a ubiquitin-dependent 
pathway, as well as yet-uncharacterized E3 ubiquitin ligases, 
cannot be excluded. Indeed, we have identifi  ed several novel 
RING fi  nger proteins that localize to the mitochondria (unpub-
lished data), some of which could mediate ubiquitin-dependent 
degradation of proteins from the OMM, including mitochon-
drial morphogenesis factors. However, as specifi  c Lys residues 
of the target proteins may be modifi  ed by ubiquitin, as well as 
SUMO, resulting in different functional consequences, it is also 
possible that both sumoylation and ubiquitylation participate in 
regulation of Drp-1–dependent mitochondrial fi  ssion.
Materials and methods
Cell culture and transfection
HeLa cells (American Type Culture Collection) were cultured in complete 
Dulbecco’s minimum essential medium supplemented with 10% heat-
inactivated fetal calf serum, 100 U/ml penicillin, and 100 μg/ml strepto-
mycin in 5% CO2 at 37°C. Wild-type, Mfn1KO, and Mfn2 KO cells were 
cultured as described previously (Karbowski et al., 2004, 2006). Transfec-
tions were performed using FuGENE 6 (Roche) according to the manufac-
turer’s instructions.
Mammalian expression vectors, mutagenesis, and RNA interference
Human MARCH5 (GenBank/EMBL/DDBJ accession no. NM_017824) was 
ampliﬁ  ed using the proof reading polymerase Pfx (Invitrogen) from IMAGE 
clone #3905766 (Invitrogen) with the following primers: 5′-ATCG-
CCTCGAGCCA  T  G  C  C  G  G  A  C  C  A  A  G  C  C  C  T  A  C  A  -3′ and 5′-A  C  T  A  G  G  G  A  T  C-
C  C  G  T  G  C  T  T  C  T  T  C  T  T  G  T  T  C  T  G  G  A  T  A  A  T  T  -3′ and cloned into the XhoI and BamHI 
site of YFP-N1 and YFP-C1 (BD Biosciences) to generate YFP-MARCH5 
and MARCH5-YFP. MARCH5
H43W-YFP and MARCH5
C65S,C68S-YFP were 
generated using the mutagenic primers: 5′-G  A  G  G  A  T  C  T  A  C  A  A  A  A  T  G  G  G-
T  T  TGGCAAGC  TT  G  T  C  T  A  C  A  A  C  G  C  T  G  G  G  T  G  -3′ and 5′-C  A  C  C  C  A  G  C  G  T  T  G  T-
A  G  A  C  A  A  G  C  T  T  G  C  C  A  A  A  C  C  C  A  T  T  T  T  G  T  A  G  A  T  C  C  T  C  -3′ for MARCH5
H43W-YFP 
and 5′-G  T  A  C  A  G  C  C  A  G  A  G  T  G  G  C  A  T  C  T  C  C  A  T  G  G  T  C  C  A  A  T  G  C  T  G  A  A  T  A  C  C  T  A-
A  T  A  G  -3′ and 5′-C  T  A  T  T  A  G  G  T  A  T  T  C  A  G  C  A  T  T  G  G  A  C  C  A  T  G  G  A  G  A  T  G  C  C  A  C  T  C  T-
G  G  C  T  G  T  A  C  -3′ for and MARCH5
C65S,C68S-YFP and Pfu polymerase (Stratagene) 
with MARCH5-YFP as template. MARCH5
∆1-71 was obtained using the follow-
ing primers: 5′-ATCGCCTCGAGCCATG G  C  T  G  A  A  T  A  C  C  T  A  A  T  A  G  T  T  T  T  T  C  C  -3′ 
and 5′-ACTAGGGATCCCGT  G  C  T  T  C  T  T  C  T  T  G  T  T  C  T  G  G  A  T  A  A  T  T  -3′ and cloned 
XhoI/BamHI into YFP-N1 to generate MARCH5
∆1-71-YFP. All constructs were 
veriﬁ  ed by sequencing. The mouse Mfn2 expression vector (Chen et al., 2003) 
was provided by D. Chan (Caltech, Pasadena, CA).
The short hairpin RNAi was performed as described previously (Lee 
et al., 2004). The oligonucleotides used for MARCH5 shRNAi generation 
were: 5′-C  T  G  G  A  A  T  T  C  G  A  G  G  A  A  C  A  G  G  A  C  A  A  C  C  T  A  T  G  A  A  G  C  T  T  G  A  T  A  G  G-
T  T  G  T  C  T  T  G  T  T  C  T  T  C  G  A  A  T  T  C  T  A  G  T  T  G  T  T  T  T  T  T  G  -3′, and 5′-G  A  T  C  C  A  A  A  A  A  A-
C  A  A  C  T  A  G  A  A  T  T  C  G  A  A  G  A  A  C  A  A  G  A  C  A  A  C  C  T  A  T  C  A  A  G  C  T  T  C  A  T  A  G  G  T  T  G  T  C  C-
T  G  T  T  C  C  T  C  G  A  A  T  T  C  C  A  G  C  G  -3′. Drp1 shRNAi- and control GFP shRNAi-
generating vectors were used as described previously (Lee et al., 2004).
Confocal microscopy analysis
For confocal microscopy analyses cells were cultured in 2-well chambered 
Borosilicate coverglasses (Nunc). Images were captured using an LSM510 
Meta imaging station (Carl Zeiss MicroImaging, Inc.). The images of immuno-
stained, ﬁ  xed cells were acquired with 100×/1.4 color corrected Plan-
Apochromat (Carl Zeiss MicroImaging, Inc.) objective lens. For live cell 
imaging, cells were maintained at 35°C for no longer than 30 min and 
imaged using 100×/1.45 α-Plan-FLUAR objective lens (Carl Zeiss Micro-
Imaging, Inc.). FRAP analysis of mitochondrial volume was performed as 
described previously (Szabadkai et al., 2004; Karbowski et al., 2006), 
unless stated otherwise. Subcellular mobility of Drp1 was determined using 
FRAP analysis of YFP-Drp1. Cells were cotransfected with YFP-Drp1 and 
CFP fused MARCH5 constructs in the molar ratio 1:5. The 4-μm strip was 
photobleached in YFP-Drp1 expressing cells using a 30.0-mV argon laser set 
to 514 nm with 50% of the laser power output and 100% of transmission. 
This was followed by the time-lapse 12-bit image acquisition of YFP-Drp1 
ﬂ  uorescence recovery with the same laser set to 50% of the laser power 
output and 1% of transmission. Time-lapse imaging was performed for 
19.66 s after photobleaching with the interval of 400 ms. The detec-
tor gain was maintained at the levels below saturation of the brightest 
structures, resulting in FRAP of mostly focal Drp1. The FRAP curves were 
obtained using LSM510 software (Carl Zeiss MicroImaging, Inc.). The 
photoactivation studies of mitochondrial matrix targeted photoactivable 
GFP (mito-PAGFP) were performed as described previously (Karbowski 
et al., 2004). For the mito-PAGFP and FRAP analysis in cotransfected 
cells, cells expressing WT MARCH5 and MARCH5 RING mutants were 
identiﬁ  ed by CFP ﬂ  uorescence.
Immunoﬂ  uorescence and colocalization analysis
Cells were ﬁ  xed with 4% paraformaldehyde in PBS for 30 min, permeabi-
lized with 0.15% Triton X-100 for 20 min, and then blocked with 10% BSA 
for 45 min at room temperature. The cells were then immunostained for 
90 min at RT, or overnight at 4°C with the following primary antibodies: 
anti-cytochrome c mAbs (BD Biosciences; 1:250), anti-Tom20 mAbs (BD 
Biosciences; 1:250), anti-Tom20 polyclonal antibodies (Santa Cruz Bio-
technology, Inc.; 1:500), anti-Dlp1 mAbs (Drp1; clone 8; BD Biosciences; 
1:100), and anti-Myc mAbs (Santa Cruz Biotechnology, Inc., 1:1,000). 
Cells were washed and stained with AlexaFluor (488-, 546- and 633)-
conjugated secondary antibodies (BD Biosciences; 1:250) for 1 h at RT. 
For the colocalization assay the projections of 12-bit confocal z-sections 
covering the entire depth of the cell, obtained with an interval of 0.25 μm, 
were used. Images in all experimental groups were obtained with the same 
settings of the confocal microscope, except for detector gain adjustments 
in the green channel that were performed to normalize saturations levels. 
Images were analyzed using the colocalization menu of the Volocity soft-
ware (Improvision). The ROIs covering the entire area of the cell were created, 
followed then by the adjustment of the red-channel lower threshold used in 
order to exclude background staining from further analysis. The colocalization 
statistics were determined from the points included within ROIs and pre-
sented as Pearson’s Correlation values that can vary between −1 and 1. 
Pearson’s Correlation reﬂ   ects the linear relationship between two vari-
ables. When applied to image analysis it can be used to establish the sta-
tistical signiﬁ  cance of the association of pixels from different channels of 
confocal images, and therefore to determine the colocalization degree of 
different proteins in the cell. A correlation of zero means that there is no 
linear relationship between the variables whereas a correlation of 1 indi-
cates perfect positive linear relationship.
MARCH5 antibody generation
For antibody production, full-length MARCH5 was ampliﬁ  ed using 5′-A  A  C  T-
A  G  C  A  T  A  T  G  C  C  G  G  A  C  C  A  A  G  C  C  C  T  A  C  A  -3′ and 5′-A  C  T  A  G  G  G  A  T  C  C  T  T  A  T  G-
C  T  T  C  T  T  C  T  T  G  T  T  C  T  G  G  A  T  A  -3′ and cloned into pET15b (CLONTECH 
Laboratories, Inc.) using NdeI/BamHI to obtain pET15b-MARCH5. Esche-
richia coli were transformed with pET15b-MARCH5. The inclusion bodies 
containing full-length 
HIS6MARCH5 were isolated and solubilized in denatur-
izing bind buffer (20 mM Tris, pH 7.4, 500 mM NaCl, 40 mM imidazole, 
and 6M Guanindium HCl) and puriﬁ  ed using HISTrap HP (GE Healthcare) 
according to the manufacturer’s suggestions. 
HIS6MARCH5 was refolded 
by dialysis against refolding buffer (20 mM Tris, pH 8.0, 500 mM NaCl, 
500 mM Arginin/HCl, and 0.2% Triton X-100). MARCH5-speciﬁ  c antibod-
ies were raised using recombinant full-length 
HIS6MARCH5 injected into a 
New Zealand White rabbit. The antibodies were afﬁ  nity puriﬁ  ed from 
rabbit serum using 
HIS6MARCH5 bound to HiTrap NHS-activated HP 
(GE Healthcare) according to the manufacturer’s recommendations. Anti-
Mfn2 polyclonal antibodies were obtained using the same protocol, with 
the 1–405 Mfn2 fragment used to immunize rabbits.
Cell fractionation, chemical cross-linking, and Western blot
For Western blot analysis HeLa cells were transfected with 
Myc3MARCH5, 
Myc3MARCH5
H43W, or control vector (YFP-N1; CLONTECH Laboratories, 
Inc.) using Effectene (QIAGEN) according to the manufacturer’s recom-
mendation. Cells were harvested 18 h after transfection and then sus-
pended in cell lysis buffer (250 mM Sucrose, 20 mM Hepes/KOH, pH 7.5, 
10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, and complete 
protease inhibitor [Roche]). Cells were disrupted by 15 passages through 
a 25-gauge needle (with 1-ml syringe). The heavy membrane fraction (HM) 
was obtained by centrifugation at 10,000 g for 10 min. For cross-linking 
experiments the HM fraction was resuspended in lysis buffer and incubated 
on ice for 30 min either with 1 mM BMH (Pierce Chemical Co.) or with MARCH5 AND MITOCHONDRIAL FISSION • KARBOWSKI ET AL. 83
DMSO as control. The reaction was stopped by addition of 100 mM gly-
cine, and samples were boiled in SDS PAGE sample buffer and analyzed 
by Western blot. The commercial antibodies used in Western blot analysis 
were: anti-Drp1 (Dlp1) mAbs (clone 8; BD Biosciences), anti-Hsp60 mAbs 
(StressGen Biotechnologies), anti-α-tubulin mAbs (Sigma-Aldrich), and anti-
Fis1 polyclonal antibodies (Biovision).
Online supplemental material
Supplemental text describes additional analyses of mitochondrial pheno-
types in MARCH5-expressing cells. Figs. S1 and S2 show additional exam-
ples of mitochondrial phenotypes in MARCH5 RING mutant transfected 
cells. Fig. S3 shows FRAP analysis in cells expressing high amounts of 
MARCH5
H43W. Fig. S4 shows analyses of the oligomeric state of MARCH5. 
Fig. S5 demonstrates the degree of colocalization of Drp1, Drp1
K38A, and 
Fis1 with MARCH5
H43W. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200611064/DC1.
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